Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Open-label randomized phase 2 study of group versus individual MDMA-assisted therapy for PTSD after the October 7, 2023 events
MOH_2025-07-10_014193Phase 2Recruiting
- Sponsor
- ד"ר רויטל עמיאז
- Start
- Apr 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of midomafetamine in post-traumatic stress disorder (PTSD) (2 arms), sponsored by ד"ר רויטל עמיאז. Started Apr 2025; status: recruiting.
02
Drugs
midomafetamine
03
Conditions
post-traumatic stress disorder (PTSD)
Beyond the preview
Go deeper on MOH_2025-07-10_014193.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on MOH_2025-07-10_014193.